The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling

AIMS: Although clinical guidelines advocate the use of the highest tolerated dose of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute myocardial infarction (MI), the optimal dosing or the risk–benefit profile of different doses have not been fully identified. MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Park, Kyungil, Kim, Young‐Dae, Kim, Ki‐Sik, Lee, Su‐Hoon, Park, Tae‐Ho, Lee, Sang‐Gon, Kim, Byung‐Soo, Hur, Seung‐Ho, Yang, Tae‐Hyun, Oh, Joo‐Hyun, Hong, Taek‐Jong, Park, Jong‐Sun, Hwang, Jin‐Yong, Jeong, Byungcheon, Bae, Woo‐Hyung
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5880661/
https://ncbi.nlm.nih.gov/pubmed/29341471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12249
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars